All posts by: Michael Zand

About Michael Zand

Stem Cell Transplant Patients Benefit From Inpatient Palliative Care – Oncology Nurse Advisor

Continue reading

2017-06-03 NEWS

Oncology Nurse Advisor

Stem Cell Transplant Patients Benefit From Inpatient Palliative Care
Oncology Nurse Advisor
CHICAGO — Inpatient palliative care integrated with hematopoietic stem cell transplantation (HSCT) care is associated with improvements in depression and symptoms of post-traumatic stress disorder (PTSD) at 6 months after transplantation …

Continue reading

2017-06-03 NEWS

STAT

U.S. could save $825 million a year with a small change in immunotherapy dosing, study says
STAT
That’s the finding of a new study on the immunotherapy drug pembrolizumab, marketed commercially as Keytruda by Merck. By switching to weight-based dosing — instead of a fixed dose of 200 mg — doctors could quickly reduce costs of the intravenous …

Continue reading

2017-06-03 NEWS

Wall Street Pit

CRISPR Found To Have A Dangerous Side-Effect: Unwanted Mutations
Wall Street Pit
People have been calling the CRISPR gene editing technology revolutionary for good reason: there’s no doubt that if used properly, it has the potential to cure many of the world’s worst diseases and medical disorders. And yet the fear that it can be …
Unexpected mutations after CRISPR gene-editingBioEdge

all 2 news articles »

Continue reading

2017-06-03 NEWS

WOAI

MS patients await governor’s signature on bill allowing adult stem cell therapy
WOAI
Cowley said Celltex in Houston does a mini-liposuction, extracting a few tablespoons of her fan, then prepares the hundreds of millions of stem cells. She has traveled to Cancun several times so a private hospital there can set up an hour-long IV to …

and more »

Continue reading

2017-06-03 NEWS

WOAI

MS patients await governor’s signature on bill allowing adult stem …
WOAI
SAN ANTONIO – Some terminally and chronically ill patients are eagerly awaiting the governor’s signature on a bill they believe will help thousands of Texans.

and more »